Abstract
Inoperable locally advanced or inoperable recurrent rectal cancer is a difficult problem. Tenesmus, discharge, bleeding and pelvic pain are frequently present and often are associated with infiltration of the sacral plexus. The value of radiotherapy in managing such patients is being appreciated, although up to 40% of the treated patients have no symptomatic response. Improvement in tumor response and control has been scored through efforts to overcome the radioresistance of the hypoxic tumor cells by neutron irradiation. This article is an account of the activity of neutron radiotherapy in such patients. Over 350 patients were entered in studies comparing neutrons used alone and neutrons used in a mixed-beam treatment schedule. At present no therapeutic gain for long-lasting survival has been achieved; however, local control and pain improvement seems to be better with neutrons than with photons.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Athlin L, Bengtsson NO, Stenling R (1988) Local recurrence and survival after radical resection of rectal carcinoma. Acta Chir Scand 154: 225–229
Battermann JJ, Hart GAM, Breur K (1981) Dose-effect relations for tumour control and complication rate after fast neutron therapy for pelvic tumors. Br J Radiol 54: 899–904
Battermann JJ (1982) Results of dT fast neutron irradiation on advanced tumors of bladder and rectum. Int J Radiat Oncol Biol Phys 8: 2159–2164
Breteau N, Destembert B, Favre A, Sabattier R, Schlienger M (1986) An interim assessment of the experience of fast neutron boost in inoperable rectal carcinoma in Orléans. Bull Cancer/Radiother 73: 591–595
Caderao JB, Hussey DH, Fletcher DH, Sampiere VA, Johnson DE, Wahrton JT (1976) Fast neutron radiotherapy for locally advanced pelvic cancer. Cancer 37: 2620–2629
Cohen L, Saroja KR, Hendrickson FR, Lennox AJ, Hatcher MA, Kroc TK (1995) Neutron irradiation of human pelvic tissues yields a steep dose-response function for late sequelae. Int J Rad Oncol Biol Phys 32: 367–372
Duncan W, Arnott SJ, Jack WJL, Orr JA, Kerr GR, Williams JR (1987) Results of two randomised clinical trials of neutron therapy in rectal adenocarcinoma. Radioth Oncol 8: 191–198
Eble M, Wulf J, van Kampen M, Weischädel U, Wannenmacher M (1995) Lokal begrenzte Dosiseskalation in der Radiotherapie des primär ausgedehnten und lokal rezidivierten Rektumkarzinoms. Strahlenther Onkol 171: 77–86
Eising E, Pötter R, Haverkamp U, Schnepper E (1990) Neutron therapy (dT, 14 MeV) for re- currents of rectal cancer: interim analyses from Münster. Strahlenther Onkol 166: 90–94
Engenhart R, Kimmig B, Marin Grez M, Höver KH, Flentje M, zum Winkel K (1989) Combined neutron photon therapy of locally recurrent rectosigmoidal tumors. Strahlenther Onkol 165: 327–329
Engenhart R, Kimmig B, Wannenmacher M, Höver KH, Hesse BM, Lorenz JW (1989) Experience with the computer controlled weighted moving beam therapy (WMBT) in routine clinical use. In: Blattmann H (ed) Proceedings of the International Heavy Particle Therapy Workshop ( PTCOG/EORTC/ECNEU ), Villingen 1989, pp 38–42
Engenhart R, Kimmig B, Höver KH, Strauss LG, Lorenz WI, Wannenmacher M (1990) Photon-neutron therapy for recurrent colorectal cancer-follow up and preliminary re-suits. Strahlenther Onkol 166: 95–98
Engenhart R, Kimmig B, Strauß G, Höver KH, Rohman J, Haberkorn U, van Kaick G, Wannenmacher M (1992) Therapy monitoring of presacral recurrences after high-dose irradiation: value of PET, CT, CEA and pain score. Strahlenther Onkol 4: 203–212
Errington RB, Ashby D, Gore SM, Abrams KR, Myint S, Bonnett DE, Blake SW, Saxton TE (1991) High energy neutron treatment for pelvic cancers: study stopped because of increased mortality. BMJ 302: 1045–1051
Field SB, Fowler JF (1984) The biological basis for neutron therapy. J Eur Radiother 3: 170–175
Flentje M, Frey M, Kuttig H, Kimmig M (1988) Strahlentherapie bei Lokalrezidiven colorektaler Tumoren. Prognostische Faktoren, Verlaufsdiagnostik und Ergebnisse. Strahlenther Onkol 164: 402–407
Frykholm G, Glimelius B, Pahiman L (1993) Pre-and postoperative irradiation in adenocarcinoma of the rectum. Final treatment results of a randomized trial and an evaluation of late secondary effects. Dis Colon Rectum 36: 564–572
Gerard A, Berrod JL, Pene F, Loygue J, Langier A, Bruckner R, Camelot G, Arnand JP, Metzger U, Buyse M, Dalesio O, Duez N (1985) Interim analysis of a phase III study on preoperative radiation therapy in resectable rectal carcinoma. Cancer 55: 2373–2379
Goldmann PA Nicholls RJ (1995) Prediction of local recurrence and survival of carcinoma of the rectum by surgical and histopathological assessment of local clearance. Br J Surg 82: 1054–1056
Gunderson L, Cohen AC, Dosoretz DD, Ship WU, Hedberg SE, Wood WC, Rodkey GV (1983) Residual, unresectable, or recurrent colorectal cancer: external beam irradiation and intraoperative electron beam boost-resection. Int J Radiat Oncol Biol Phys 9: 1597–1603
Heald RJ, Ryall RDH (1986) Recurrence and survival after total mesorectal excision for rectal cancer. Lancet 2: 1479–1482
Herfarth Ch, Schlag P, Hohenberger P (1985) Möglichkeiten bei locoregionären Rezidiven der Carcinome des Gastrointestinaltraktes. Chirurg 56: 492–498
Krook JE, Moertel CG, Gunderson LL et al (1991) Effective surgical adjuvant therapy for high-risk rectal carcinoma. N Engl J Med 324: 709–715
Lanciano RM, Calkins AR, Wolkov HB, Budzydlowski J, Noyes RD et al (1993) A phase I/II study of intraoperative radiotherapy in advanced unresectable or recurrent carcinoma of the rectum: a RTOG study. J Surg Oncol 1: 20–29
Moertel CG, Gunderson LL, Mailliard JA, McKenna PJ, Martenso JA, Burch, PA, Cha SS (1994) Early evaluation of combined fluorouracil and leucovorin as a radiation enhancer for locally unresectable, residual, or recurrent gastrointestinal carcinoma. The North Central Cancer Treatment Group. J Clin Oncol 1: 21–27
Overgaard M, Overgaard J, Sell A (1984) Dose response relationship for radiation therapy of recurrent, residual and primarily inoperable colorectal cancer. Radiother Oncol 1: 217–225
Pacini P, Cionini L, Pirtoli L, Ciatto S, Tucci E, Sebaste L (1986) Symptomatic recurrences of,carcinomas of the rectum and sigmoid. The influence of radiotherapy on the quality of life. Dis Colon Rect 29: 865–868
Peak MJ, Wang L, Hill CK, Peak JG (1991) Comparison of repair of DNA double-strand breaks caused by neutron or gamma radiation in cultured human cells. Int J Radiat Biol 60: 891–898
Prott FJ, Pötter R, Preusser PO, Micke O, Schouwing A, Willich N (1997) Ergebnisse der Behandlung von Rektumkarzinomrezidiven mit schnellen Neutronen (dT 14 MeV). Strahlenther Onkol 173: 316–322
Rominger CJ, Helber RD, Gunderson LL et al (1985) Radiation therapy alone or in combination with chemotherapy in the treatment of residual or inoperable carcinoma of the rectum and rectosigmoid or pelvic recurrence following colorectal surgery: Radiation Therapy Oncology Group study (76–16). Am J Clin Oncol 8: 118–127
Tong D, Gillick L, Hendrickson FR (1982) The palliation of symptomatic osseous metastases. Cancer 50: 893–899
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1998 Springer-Verlag Berlin · Heidelberg
About this paper
Cite this paper
Engenhart-Cabillic, R. et al. (1998). Use of Neutron Therapy in the Management of Locally Advanced Nonresectable Primary or Recurrent Rectal Cancer. In: Engenhart-Cabillic, R., Wambersie, A. (eds) Fast Neutrons and High-LET Particles in Cancer Therapy. Recent Results in Cancer Research, vol 150. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-78774-4_6
Download citation
DOI: https://doi.org/10.1007/978-3-642-78774-4_6
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-78776-8
Online ISBN: 978-3-642-78774-4
eBook Packages: Springer Book Archive